{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:10:48Z","timestamp":1762452648868,"version":"build-2065373602"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007684","name":"Ministry of Education and Science of Ukraine","doi-asserted-by":"publisher","award":["\u0414\u0417\/174-2025","\u0414\u0417\/174-2025","\u0414\u0417\/174-2025","\u0414\u0417\/174-2025","\u0414\u0417\/174-2025"],"award-info":[{"award-number":["\u0414\u0417\/174-2025","\u0414\u0417\/174-2025","\u0414\u0417\/174-2025","\u0414\u0417\/174-2025","\u0414\u0417\/174-2025"]}],"id":[{"id":"10.13039\/501100007684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00655-8","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T01:26:48Z","timestamp":1756862808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidimensional in silico evaluation of fluorine-18 radiopharmaceuticals: integrating pharmacokinetics, ADMET, and clustering for diagnostic stratification"],"prefix":"10.1007","volume":"39","author":[{"given":"Valeriya","family":"Trusova","sequence":"first","affiliation":[]},{"given":"Uliana","family":"Malovytsia","sequence":"additional","affiliation":[]},{"given":"Pylyp","family":"Kuznietsov","sequence":"additional","affiliation":[]},{"given":"Ivan","family":"Yakymenko","sequence":"additional","affiliation":[]},{"given":"Galyna","family":"Gorbenko","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"655_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","volume":"23","author":"J Schwenck","year":"2023","unstructured":"Schwenck J et al (2023) Advances in PET imaging of cancer. Nat Rev Cancer 23:474","journal-title":"Nat Rev Cancer"},{"key":"655_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.739130","volume":"12","author":"R Zhou","year":"2021","unstructured":"Zhou R et al (2021) Pet imaging of neuroinflammation in Alzheimer\u2019s disease. Front Immunol 12:739130","journal-title":"Front Immunol"},{"key":"655_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2967\/jnumed.120.257238","volume":"62","author":"A Farolfi","year":"2021","unstructured":"Farolfi A et al (2021) Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer. J Nucl Med 62:596","journal-title":"J Nucl Med"},{"key":"655_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G et al (2020) Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol 19:951","journal-title":"Lancet Neurol"},{"key":"655_CR5","volume":"37","author":"S Vallabhajosula","year":"2007","unstructured":"Vallabhajosula S (2007) (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization Semin. Nucl Med 37:400","journal-title":"Nucl Med"},{"key":"655_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121641","volume":"17","author":"A Dimitrakopoulou-Strauss","year":"2024","unstructured":"Dimitrakopoulou-Strauss A et al (2024) Non-[18F]FDG PET-radiopharmaceuticals in oncology. Pharmaceuticals (Basel) 17:1641","journal-title":"Pharmaceuticals (Basel)"},{"key":"655_CR7","first-page":"268","volume":"8","author":"L Filippi","year":"2018","unstructured":"Filippi L et al (2018) 18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer\u2019s disease Am. J Nucl Med Mol Imaging 8:268","journal-title":"J Nucl Med Mol Imaging"},{"key":"655_CR8","first-page":"55","volume":"2","author":"M Alauddin","year":"2012","unstructured":"Alauddin M (2012) Positron emission tomography (PET) imaging with (18)F-based radiopharmaceuticals. Am J Nucl Med Mol Imaging 2:55","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"655_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2967\/jnumed.121.263518","volume":"63","author":"AR Pantel","year":"2022","unstructured":"Pantel AR et al (2022) Principles of radiopharmaceutical kinetic analysis in oncology, part I: principles and overview of methodology. J Nucl Med 63:342","journal-title":"J Nucl Med"},{"key":"655_CR10","volume-title":"Radiopharmaceutical chemistry","author":"M Lubberink","year":"2019","unstructured":"Lubberink M (2019) Kinetic modeling of radiopharmaceuticals. In: Lewis J, Windhorst A, Zeglis B (eds) Radiopharmaceutical chemistry. Springer, Cham"},{"key":"655_CR11","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.7150\/thno.77279","volume":"12","author":"H Siebinga","year":"2022","unstructured":"Siebinga H et al (2022) Current use and future potential of physiologically based pharmacokinetic modelling of radiopharmaceuticals a review. Theranostics 12:7804","journal-title":"Theranostics"},{"key":"655_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1590\/s1677-5538.ibju.2023.0312","volume":"49","author":"S-H Chen","year":"2024","unstructured":"Chen S-H et al (2024) Head-to-head comparisons of enhanced CT, 68Ga-PSMA-11 PET\/CT and 18F-FDG PET\/CT in identifying adverse pathology of clear-cell renal cell carcinoma: a prospective study Int. Braz J Urol 49:716","journal-title":"Braz J Urol"},{"key":"655_CR13","first-page":"1","volume":"6","author":"S Vangala","year":"2012","unstructured":"Vangala S et al (2012) Translational drug discovery research: integration of medicinal chemistry, computational modeling, pharmacology ADME, and toxicology. Encyclopedia Drug Metabolism Interact 6:1","journal-title":"Encyclopedia Drug Metabolism Interact"},{"key":"655_CR14","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v8.i11.880","volume":"8","author":"K Kawada","year":"2016","unstructured":"Kawada K et al (2016) Mechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancer. World J Radiol 8:880","journal-title":"World J Radiol"},{"key":"655_CR15","first-page":"555946","volume":"16","author":"CDAM Maurino","year":"2020","unstructured":"Maurino CDAM et al (2020) The use of 18F-FDG in oncology and its applications in neuroblastomas Canc. Therapy & Oncol. Int. J. 16:555946","journal-title":"Therapy & Oncol. Int. J."},{"key":"655_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ph17091228","volume":"17","author":"JA Robert","year":"2024","unstructured":"Robert JA et al (2024) Contribution of [18F]FET PET in the management of gliomas, from diagnosis to follow-up: a review. Pharmaceuticals (Basel) 17:1228","journal-title":"Pharmaceuticals (Basel)"},{"key":"655_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.721821","volume":"11","author":"M Celli","year":"2021","unstructured":"Celli M et al (2021) Diagnostic and prognostic potential of 18F-FET PET in the differential diagnosis of glioma recurrence and treatment-induced changes after chemoradiation therapy. Front Oncol 11:721821","journal-title":"Front Oncol"},{"key":"655_CR18","first-page":"64","volume":"11","author":"G Masselli","year":"2021","unstructured":"Masselli G et al (2021) Clinical application of 18F-DOPA PET\/TC in pediatric patients. Am J Nuclear Med Mol Imaging. 11:64","journal-title":"Am J Nuclear Med Mol Imaging."},{"key":"655_CR19","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2967\/jnumed.117.190892","volume":"58","author":"M Grkovski","year":"2017","unstructured":"Grkovski M et al (2017) 18F-fluoromisonidazole kinetic modeling for characterization of tumor perfusion and hypoxia in response to antiangiogenic therapy. J Nucl Med 58:1567","journal-title":"J Nucl Med"},{"key":"655_CR20","first-page":"446","volume":"51","author":"E McKinley","year":"2010","unstructured":"McKinley E et al (2010) Thymidine salvage to reflect tumor cell proliferation: implications for 18F-FLT PET as a biomarker in oncology. J Nucl Med 51:446","journal-title":"J Nucl Med"},{"key":"655_CR21","first-page":"371","volume":"46","author":"M Muzi","year":"2005","unstructured":"Muzi M (2005) Kinetic modeling of 3\u2019-deoxy-3\u2019-fluorothymidine in somatic tumors: mathematical studies. J Nucl Med 46:371","journal-title":"J Nucl Med"},{"key":"655_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L et al (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52:W422","journal-title":"Nucleic Acids Res"},{"key":"655_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btl485","volume":"22","author":"S Hoops","year":"2006","unstructured":"Hoops S et al (2006) COPASI: a COmplex PAthway SImulator. Bioinformatics 22:3067","journal-title":"Bioinformatics"},{"key":"655_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-021-00623-2","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J et al (2021) Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function. BMC Med Imaging 21:90","journal-title":"BMC Med Imaging"},{"key":"655_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00259-003-1118-0","volume":"30","author":"D Pauleit","year":"2003","unstructured":"Pauleit D et al (2003) Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine. Eur J Nucl Med Mol Imaging 30:519","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"655_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4274\/mirt.galenos.2021.08831","volume":"30","author":"W Buratachwatanasiri","year":"2021","unstructured":"Buratachwatanasiri W et al (2021) Pharmacokinetic modeling of 18F-FDOPA PET in the human brain for early Parkinson\u2019s disease Mol. Imaging Radionucl Ther 30:69","journal-title":"Imaging Radionucl Ther"},{"key":"655_CR27","first-page":"333","volume":"33","author":"S Okazumi","year":"1992","unstructured":"Okazumi S et al (1992) Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 33:333","journal-title":"J Nucl Med"},{"key":"655_CR28","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s00259-004-1590-1","volume":"31","author":"G P\u00f6pperl","year":"2004","unstructured":"P\u00f6pperl G et al (2004) Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma Eur. J Nucl Med Mol Imaging 31:1464","journal-title":"J Nucl Med Mol Imaging"},{"key":"655_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ymeth.2017.05.019","volume":"130","author":"KJ Langen","year":"2017","unstructured":"Langen KJ (2017) Imaging of amino acid transport in brain tumours: positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine (FET). Methods 130:124","journal-title":"Methods"},{"key":"655_CR30","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2967\/jnumed.106.039321","volume":"48","author":"C Schiepers","year":"2007","unstructured":"Schiepers C (2007) 18F-FDOPA kinetics in brain tumors. J Nucl Med 48:1651","journal-title":"J Nucl Med"},{"key":"655_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2967\/jnumed.109.067009","volume":"51","author":"W Wang","year":"2010","unstructured":"Wang W (2010) Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer. J Nucl Med 51:37\u201345","journal-title":"J Nucl Med"},{"key":"655_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33160-0","volume":"8","author":"F Morschhauser","year":"2018","unstructured":"Morschhauser F et al (2018) A new pharmacokinetic model for 90Y-ibritumomab tiuxetan based on 3-dimensional dosimetry. Sci Rep 8:14860","journal-title":"Sci Rep"},{"key":"655_CR33","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/MNM.0000000000001592","volume":"43","author":"KK Wong","year":"2022","unstructured":"Wong KK et al (2022) Differences in tumor-to-normal organ SUV ratios measured with 68Ga-DOTATATE PET compared with 177Lu-DOTATATE SPECT in patients with neuroendocrine tumors. Nucl Med Commun 43:892","journal-title":"Nucl Med Commun"},{"key":"655_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.118.007965","volume":"11","author":"D Raffel","year":"2018","unstructured":"Raffel D et al (2018) First-in-human studies of [18f] fluorohydroxyphenethylguanidines circ. Cardiovasc Imaging 11:e007965","journal-title":"Cardiovasc Imaging"},{"key":"655_CR35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1049\/iet-syb.2011.0015","volume":"5","author":"Z Zi","year":"2011","unstructured":"Zi Z (2011) Sensitivity analysis approaches applied to systems biology models. IET Syst Biol 5:336","journal-title":"IET Syst Biol"},{"key":"655_CR36","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3109\/0284186X.2010.498831","volume":"49","author":"K R\u00f8e","year":"2010","unstructured":"R\u00f8e K et al (2010) Preclinical dynamic 18F-FDG PET tumor characterization and radiotherapy response assessment by kinetic compartment analysis. Acta Oncol 49:914","journal-title":"Acta Oncol"},{"key":"655_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1039\/C8MD00472B","volume":"10","author":"L Guan","year":"2018","unstructured":"Guan L et al (2018) ADMET-score: a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm 10:148","journal-title":"Medchemcomm"},{"key":"655_CR38","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.2967\/jnumed.116.180612","volume":"58","author":"M Richard","year":"2017","unstructured":"Richard M et al (2017) Determination of an optimal pharmacokinetic model of 18F-FET for quantitative applications in rat brain tumors. J Nucl Med 58:1278","journal-title":"J Nucl Med"},{"key":"655_CR39","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2967\/jnumed.116.180422","volume":"58","author":"J Schwartz","year":"2017","unstructured":"Schwartz J et al (2017) Pharmacokinetic analysis of dynamic 18F-fluoromisonidazole PET data in non-small cell lung cancer. J Nucl Med 58:911","journal-title":"J Nucl Med"},{"key":"655_CR40","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2967\/jnumed.119.240598","volume":"61","author":"R Sharma","year":"2020","unstructured":"Sharma R et al (2020) Monitoring response to transarterial chemoembolization in hepatocellular carcinoma using 18F-fluorothymidine PET. J Nucl Med 61:1743","journal-title":"J Nucl Med"},{"key":"655_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33034-5","volume":"8","author":"C Debus","year":"2018","unstructured":"Debus C et al (2018) Feasibility and robustness of dynamic 18F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation. Sci Rep 8:14760","journal-title":"Sci Rep"},{"key":"655_CR42","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2967\/jnumed.114.140608","volume":"55","author":"C Lapa","year":"2014","unstructured":"Lapa C et al (2014) Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients. J Nucl Med 55:1611","journal-title":"J Nucl Med"},{"key":"655_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.735257","volume":"11","author":"T Zaragori","year":"2021","unstructured":"Zaragori T et al (2021) Dynamic 18F-FDopa PET imaging for newly diagnosed gliomas is a semiquantitative model sufficient. Front Oncol 11:735257","journal-title":"Front Oncol"},{"key":"655_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-017-0324-x","volume":"7","author":"T Puri","year":"2017","unstructured":"Puri T et al (2017) [18F]fluoromisonidazole PET in rectal cancer. EJNMMI Res 7:78","journal-title":"EJNMMI Res"},{"key":"655_CR45","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/neuonc\/not199","volume":"16","author":"C Kratochwil","year":"2014","unstructured":"Kratochwil C et al (2014) Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors. Neuro Oncol 16:434","journal-title":"Neuro Oncol"},{"key":"655_CR46","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1109\/TRPMS.2020.3031274","volume":"4","author":"Y Zuo","year":"2020","unstructured":"Zuo Y et al (2020) Multiparametric cardiac 18F-FDG PET in humans kinetic model selection and identifiability analysis. IEEE Trans Radiat Plasma Med Sci 4:759","journal-title":"IEEE Trans Radiat Plasma Med Sci"},{"key":"655_CR47","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00261-016-0947-9","volume":"42","author":"M Nakajo","year":"2017","unstructured":"Nakajo M et al (2017) Current clinical status of 18F-FLT PET or PET\/CT in digestive and abdominal organ oncology. Abdom Radiol 42:951","journal-title":"Abdom Radiol"},{"key":"655_CR48","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s11307-019-01422-6","volume":"22","author":"S Thureau","year":"2020","unstructured":"Thureau S et al (2020) Comparison of hypermetabolic and hypoxic volumes delineated on [18F]FDG and [18F]fluoromisonidazole PET\/CT in non-small-cell lung cancer patients. Mol Imaging Biol 22:764","journal-title":"Mol Imaging Biol"},{"key":"655_CR49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2967\/jnumed.113.128231","volume":"55","author":"T Kawada","year":"2014","unstructured":"Kawada T (2014) Discriminating ability of 18F-FET PET for several cerebral neoplastic lesions. J Nucl Med 55:176","journal-title":"J Nucl Med"},{"key":"655_CR50","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ab1f29","volume":"64","author":"Y Zuo","year":"2019","unstructured":"Zuo Y (2019) Structural and practical identifiability of dual-input kinetic modeling in dynamic PET of liver inflammation. Phys Med Biol 64:175023","journal-title":"Phys Med Biol"},{"key":"655_CR51","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12917-018-1674-y","volume":"14","author":"C Cazer","year":"2018","unstructured":"Cazer C (2018) Expanding behavior pattern sensitivity analysis with model selection and survival analysis. BMC Vet Res 14:355","journal-title":"BMC Vet Res"},{"key":"655_CR52","first-page":"6439","volume":"35","author":"F Buroni","year":"2015","unstructured":"Buroni F et al (2015) Evidence of 18F-FCH uptake in human T98G glioblastoma cells. Anticancer Res 35:6439","journal-title":"Anticancer Res"},{"key":"655_CR53","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2967\/jnumed.114.152983","volume":"56","author":"C Lin","year":"2015","unstructured":"Lin C et al (2015) Predictive value of early-stage uptake of 3\u2019-deoxy-3\u2019-18F-fluorothymidine in cancer cells treated with charged particle irradiation. J Nucl Med 56:945","journal-title":"J Nucl Med"},{"key":"655_CR54","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1021\/acs.jmedchem.2c01824","volume":"66","author":"F Cornelissen","year":"2023","unstructured":"Cornelissen F et al (2023) Explaining blood-brain barrier permeability of small molecules by integrated analysis of different transport mechanisms. J Med Chem 66:7253","journal-title":"J Med Chem"},{"key":"655_CR55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/jlcr.4019","volume":"66","author":"A Lindberg","year":"2023","unstructured":"Lindberg A et al (2023) Strategies for designing novel positron emission tomography PET radiopharmaceuticals to cross the blood-brain barrier. J Labelled Comp Radiopharm 66:205","journal-title":"J Labelled Comp Radiopharm"},{"key":"655_CR56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12149-019-01427-9","volume":"34","author":"V Romanov","year":"2020","unstructured":"Romanov V et al (2020) Evaluation of the total distribution volume of 18F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling. Ann Nucl Med 34:155","journal-title":"Ann Nucl Med"},{"key":"655_CR57","doi-asserted-by":"publisher","first-page":"14711","DOI":"10.1021\/bi035596s","volume":"42","author":"H Lee","year":"2003","unstructured":"Lee H et al (2003) Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 42:14711","journal-title":"Biochemistry"},{"key":"655_CR58","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1289\/ehp.8564199","volume":"64","author":"SN Moreno","year":"1985","unstructured":"Moreno SN et al (1985) Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis. Environ Health Perspect 64:199","journal-title":"Environ Health Perspect"},{"key":"655_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40658-022-00491-x","volume":"9","author":"D Anne-Leen","year":"2022","unstructured":"Anne-Leen D et al (2022) Principal component analysis of texture features derived from FDG PET images of melanoma lesions. EJNMMI Phys 9:64","journal-title":"EJNMMI Phys"},{"key":"655_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/jcbfm.1993.4","volume":"13","author":"KJ Friston","year":"1993","unstructured":"Friston KJ et al (1993) Functional connectivity: the principal-component analysis of large (PET) data sets. J Cereb Blood Flow Metab 13:5","journal-title":"J Cereb Blood Flow Metab"},{"key":"655_CR61","doi-asserted-by":"crossref","unstructured":"Miler-Jerkovi\u0107 V et al (2014) Clustering of time activity curves for uptake pattern assessment in dynamic nuclear medicine imaging,\u00a0In: 12th Symposium on neural network applications in electrical engineering (NEUREL) 147.","DOI":"10.1109\/NEUREL.2014.7011489"},{"key":"655_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104856","volume":"138","author":"SS Madugula","year":"2021","unstructured":"Madugula SS et al (2021) Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposing. Comput Biol Med 138:104856","journal-title":"Comput Biol Med"},{"key":"655_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"A Lammertsma","year":"1996","unstructured":"Lammertsma A et al (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153","journal-title":"Neuroimage"},{"key":"655_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1473125","volume":"15","author":"S Kemkar","year":"2024","unstructured":"Kemkar S et al (2024) Towards verifiable cancer digital twins tissue level modeling protocol for precision medicine. Front Physiol 15:1473125","journal-title":"Front Physiol"},{"key":"655_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-09948-8","volume":"33","author":"M Francone","year":"2023","unstructured":"Francone M et al (2023) Multiparametric cardiac magnetic resonance unveiling the mechanisms and early manifestations of anticancer drug cardiotoxicity. Eur Radiol 33:8439","journal-title":"Eur Radiol"},{"key":"655_CR66","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.mibio.2003.09.014","volume":"5","author":"RN Waterhouse","year":"2003","unstructured":"Waterhouse RN (2003) Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents. Mol Imaging Biol 5:376","journal-title":"Mol Imaging Biol"},{"key":"655_CR67","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/ph16020317","volume":"16","author":"CJ Hsieh","year":"2023","unstructured":"Hsieh CJ (2023) Computational chemistry for the identification of lead compounds for radiotracer development. Pharmaceuticals (Basel) 16:317","journal-title":"Pharmaceuticals (Basel)"},{"key":"655_CR68","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1177\/0271678X20985946","volume":"41","author":"EA Chowdhury","year":"2021","unstructured":"Chowdhury EA (2021) Understanding the brain uptake and permeability of small molecules through the BBB: a technical overview. J Cereb Blood Flow Metab 41:1797","journal-title":"J Cereb Blood Flow Metab"},{"key":"655_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00726","volume":"8","author":"F Wu","year":"2020","unstructured":"Wu F (2020) Computational approaches in preclinical studies on drug discovery and development. Front Chem 8:726","journal-title":"Front Chem"},{"key":"655_CR70","unstructured":"Demir E et al (2019) Computational study of radiopharmaceuticals, in\u00a0molecular docking and molecular dynamics. IntechOpen."},{"key":"655_CR71","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1021\/acs.jmedchem.4c02988","volume":"68","author":"J Stehouwer","year":"2025","unstructured":"Stehouwer J et al (2025) Structure-activity relationships and evaluation of 2-(heteroaryl-cycloalkyl)-1H-indoles as tauopathy positron emission tomography radiotracers. J Med Chem 68:6462","journal-title":"J Med Chem"},{"key":"655_CR72","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s00259-024-07020-1","volume":"52","author":"M Schottelius","year":"2025","unstructured":"Schottelius M (2025) Identifying and navigating bottlenecks in the translation of novel radiopharmaceuticals: a perspective. Eur J Nucl Med Mol Imaging 52:796","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"655_CR73","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00259-014-2959-4","volume":"42","author":"N Galldiks","year":"2015","unstructured":"Galldiks N et al (2015) Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET. Eur J Nucl Med Mol Imaging 42:685","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"655_CR74","doi-asserted-by":"publisher","first-page":"1544208","DOI":"10.1155\/2021\/1544208","volume":"2021","author":"S McGeorge","year":"2021","unstructured":"McGeorge S et al (2021) Dual-tracer positron-emission tomography using prostate-specific membrane antigen and fluorodeoxyglucose for staging of prostate cancer: a systematic review. Adv Urol 2021:1544208","journal-title":"Adv Urol"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00655-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00655-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00655-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:02:43Z","timestamp":1762452163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00655-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00655-8","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"75"}}